You are here

Home > Current news > News > Companies

Companies

BioRegion wrapup setembre

HIGHLIGHTS: New grants, first round by Alta Life Sciences, clinical trials, improvements to hospitals, licensing and acquisitions by biotech firms and news from pharma corporations

26.09.2017

The return after summer fills the BioRegion with news on research, investment and business

Ready for September

Back-to-school, are you ready?

26.09.2017

September is a good time to set new goals. Funding, internationalization, networking, professional growth… Take note of these resources and don’t miss out on these great opportunities!

Wrap-up Biocat agost

Highlights: New PERIS grants, updates from Oryzon and Almirall, crowdfunding exits, advances in oncology, antibiotic resistance and stem cells

31.08.2017

The summer break slowed down business and research activity but brought with it some news to brighten up the sector’s holidays

Wrap up Juliol: resum del mes BioRegio

Highlights: Collaboration with Baselga - Memorial Sloan-Kettering on liquid biopsy, Pi-Sunyer joins PERIS Advisory Board, Grifols’ €400-millions investment, Oryzon regains rights to ORY-1001 and new center for diagnosis of minority diseases

20.07.2017

Companies in the BioRegion continue to attract funding and move into foreign markets 

Noticia resum mes de juny BioRegió Catalunya

Highlights: Stat-Diagnostica gets €20 millions, BIO San Diego 2017, new BIST center and general director, and Albert Barberà heads up R&D in Health

29.06.2017

Companies in the BioRegion of Catalonia worked on internationalization in Asia and America in June and awards were granted to Catalan researchers, including those from Banco Sabadell Foundation and Francisco Cobos

Resum notícies mes de maig 2017

Highlights: €15 millions to treat stroke, ORION project, new talent in the BioRegion and Health 2.0 Europe

29.05.2017

Companies in the BioRegion have closed rounds of funding valued at nearly €20 millions in May and announce new hires, like Manuel Serrano at IRB Barcelona

Acord bioxclusters plus i Fenglin Biomedical Center

Agreement to facilitate access to Chinese market for European companies

29.05.2017

The bioXclusters plus consortium has signed an agreement with the Fenglin Group to provide free advisory services for SMEs looking to operate in China

Noticia mes abril Biocat

Highlights: New EMBL headquarters in Barcelona, investment valued at over €26 millions, new treatments and nominations

27.04.2017

Among the most noteworthy news stories in the BioRegion of Catalonia, Barcelona’s bid to host the EMA is moving forward and the Agbar tower is the proposed location

BIOEuropeSpring

Highlights: Investment in Inkemia and Bionure, Barcelona and the EMA, Alfonso Valencia at BSC, and the Barcelona Brain Health Initiative

29.03.2017

Among the most noteworthy news stories in the BioRegion of Catalonia this March, Barcelona boosts international positioning through several initiatives

Marc Martinell

United States grants Minoryx drug candidate orphan drug designation

07.03.2017

The drug, called MIN-102 and used to treat adrenoleukodystrophy, has also recently been granted this designation from the European Medicines Agency

Developed by Drauta